Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Siebert John M, Director. Officer active across 1 company, notably Supernus Pharmaceuticals, INC.. Aggregated, 4 reports have been logged. Activity tracked since 11 August 2021. The latest transaction was filed on 23 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
John M. Siebert is a Director at Supernus Pharmaceuticals, Inc. He brings expertise in management and strategy, contributing to the governance of the company. His role is essential in guiding strategic decisions and ensuring compliance with regulations.